Product Information
ARIPIPRAZOLE 20 MG TABLET is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.1931 per EA under NDC 33342012607. Its NADAC has been published 419 times since May 10, 2017.
FDA first approved this application on Oct 7, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342012607
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
4/23/2025
Active Ingredients
ARIPIPRAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA204111FDA Approved
10/7/2016
TE Code
AB
On Market Since
10/8/2016
Pharmacological Classes
Price Statistics
The NADAC for ARIPIPRAZOLE 20 MG TABLET has been published 419 times since May 10, 2017, and over the history we have for it it has declined 90.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1931 per EA |
|---|---|
| All-time high | $1.9701 (May 10, 2017) |
| All-time low | $0.1690 (Nov 20, 2024) |
| Median price | $0.2604 |
| Average price | $0.4052 |
| Largest weekly change | -30.7% (Jul 22, 2020) |
| Weeks tracked | 419 |
| Tracking since | May 10, 2017 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-25.1%
5Y
-23.4%
All
-90.2%
Last surveyed May 14, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 13 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 10% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Macleods Pharmaceuticals Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Aripiprazole market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Atypical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ARIPIPRAZOLE 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ARIPIPRAZOLE 20 MG TABLET, manufactured by Macleods Pharmaceuticals Limited, is $0.1931 per EA (NDC 33342012607), effective May 14, 2025.
How has the price of ARIPIPRAZOLE 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for ARIPIPRAZOLE 20 MG TABLET has declined 90.2%. It has been tracked across 419 weekly CMS publications since May 10, 2017.
What are the highest and lowest recorded NADAC prices for ARIPIPRAZOLE 20 MG TABLET?
Since May 10, 2017, the NADAC for ARIPIPRAZOLE 20 MG TABLET has ranged from a low of $0.1690 (Nov 20, 2024) to a high of $1.9701 (May 10, 2017), with a median of $0.2604 per EA.
Are there cheaper alternatives to ARIPIPRAZOLE 20 MG TABLET?
Yes. 13 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ARIPIPRAZOLE 20 MG TABLET, is $0.1743 per EA — about 10% below ARIPIPRAZOLE 20 MG TABLET.
Who manufactures ARIPIPRAZOLE 20 MG TABLET?
ARIPIPRAZOLE 20 MG TABLET (NDC 33342012607) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.